| P2093 | author name string | Fernando Gomollón | |
| P2860 | cites work | Analysis of discordance between tuberculin test and QuantiFERON-TB® Gold In-Tube in studies of contacts | Q44551617 |
| | Use of azathioprine and the risk of cancer in inflammatory bowel disease | Q45132140 |
| | Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients | Q45226332 |
| | New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients. | Q45801913 |
| | Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening. | Q47652162 |
| | Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease | Q48019757 |
| | Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. | Q53122367 |
| | Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre el uso de fármacos antifactor de necrosis tumoral α en la enfermedad inflamatoria intestinal (2013) | Q59509272 |
| | Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis | Q27000984 |
| | Safety of TNF-α inhibitors during IBD pregnancy: a systematic review | Q27008090 |
| | Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent | Q28191546 |
| | Thirty-day mortality after elective and emergency total colectomy in Danish patients with inflammatory bowel disease: a population-based nationwide cohort study | Q35882026 |
| | Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases | Q36191250 |
| | Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample | Q36959801 |
| | Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease | Q37111871 |
| | Vaccination strategies in patients with IBD. | Q38082568 |
| | Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials | Q38104612 |
| | Health maintenance and vaccination strategies in pediatric inflammatory bowel disease | Q38108219 |
| | Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease | Q38113455 |
| | Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study | Q38124655 |
| | IBD medications during pregnancy and lactation. | Q38125114 |
| | Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. | Q43681280 |
| | Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease. | Q44144568 |
| | Anti-TNF and skin inflammation in IBD: a new paradox in gastroenterology? | Q44379124 |
| P921 | main subject | inflammatory bowel diseases | Q917447 |
| P304 | page(s) | 15-20 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | Gastroenterología y Hepatología | Q27714100 |
| P1476 | title | [Safety in the diagnosis and treatment of inflammatory bowel disease]. | |
| P478 | volume | 36 Suppl 2 | |